Estados financieros detallados de OneMedNet Corporation (ONMD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
OneMedNet Corporation registró ingresos de $1.4M en el último ejercicio fiscal, con un CAGR de 5 años del 10.5%.
Márgenes de los últimos 12 meses: margen bruto -68.8%, margen operativo -7.0%, margen neto -5.8%.
Al precio actual de $0.62, ONMD presenta beneficios negativos (P/E no significativo) y un ROE del 234.63%. La capitalización bursátil es de $35M.
Cuenta de Resultados (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $824034 | $1.1M | $1.2M | $1.0M | $643000 | $1.4M |
| Coste de Ventas | $611662 | $1.2M | $1.5M | $1.1M | $924000 | $1.9M |
| Beneficio Bruto | $212372 | -$113407 | -$360000 | -$129000 | -$281000 | -$503000 |
| I+D | $307272 | $642765 | $1.6M | $2.1M | $1.5M | $1.5M |
| Generales y Administrativos | $2.4M | $1.8M | $13.8M | $4.7M | $7.9M | $7.6M |
| Gastos Operativos | $3.1M | $2.6M | $7.4M | $6.7M | $9.3M | $9.2M |
| Beneficio Operativo | -$2.9M | -$2.7M | -$7.7M | -$6.9M | -$9.6M | -$9.7M |
| EBITDA | -$2.9M | -$2.7M | -$30.4M | -$33.7M | -$9.9M | -$2.7M |
| Gastos por Intereses | 0 | $195381 | $403307 | $11000 | $147000 | $67000 |
| Beneficio Antes de Impuestos | -$2.8M | -$2.9M | -$30.4M | -$33.8M | -$10.1M | -$2.8M |
| Impuestos | 0 | 0 | $17000 | $18000 | $2000 | $1000 |
| Beneficio Neto | -$2.8M | -$2.9M | -$30.5M | -$33.8M | -$10.1M | -$2.8M |
| BPA | $-0.19 | $-0.20 | $-2.51 | $-4.77 | $-0.36 | $-0.06 |
| BPA Diluido | $-0.19 | $-0.20 | $-2.51 | $-4.77 | $-0.36 | $-0.06 |
| Acciones en Circulación (Diluidas) | $15.0M | $15.0M | $12.1M | $7.1M | $28.1M | $44.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $177000 | $891000 | $96000 | $292000 |
| Beneficio Bruto | -$222000 | $165000 | -$380000 | -$565000 |
| Beneficio Operativo | -$2.2M | -$3.1M | -$2.6M | -$2.3M |
| EBITDA | -$725000 | -$3.1M | -$2.4M | -$2.3M |
| Beneficio Neto | -$741000 | -$3.1M | -$2.5M | -$2.2M |
| BPA | $-0.02 | $-0.07 | $-0.04 | $-0.04 |
| BPA Diluido | $-0.02 | $-0.06 | $-0.04 | $-0.04 |
Balance (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $79183 | $699320 | $271000 | $47008 | $172000 | $585000 |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $2.8M | $506000 |
| Cuentas por Cobrar | $195367 | $91742 | $19000 | $151640 | $213000 | $495000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $293617 | $833293 | $391000 | $364186 | $3.6M | $2.1M |
| Inmovilizado Material | $34297 | $49768 | $83000 | $98871 | $108000 | $56000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $327914 | $883060 | $1.3M | $463057 | $3.7M | $2.2M |
| Cuentas por Pagar | 0 | 0 | $1.2M | $4.2M | $6.4M | 0 |
| Deuda a Corto | $1.1M | $3.4M | $24.7M | $4.6M | $8.8M | $350000 |
| Pasivos Corrientes | $1.5M | $4.8M | $26.1M | $12.8M | $19.2M | $4.8M |
| Deuda a Largo | $1.5M | $1.5M | $1.5M | $465023 | 0 | $220000 |
| Pasivos Totales | $3.2M | $6.6M | $27.6M | $13.3M | $19.7M | $5.1M |
| Reservas | -$22.4M | -$25.3M | -$57.7M | -$55.1M | -$101.6M | -$104.4M |
| Patrimonio Neto | -$2.9M | -$5.7M | -$26.4M | -$12.9M | -$15.9M | -$3.0M |
| Deuda Total | $2.6M | $4.9M | $26.2M | $5.1M | $8.8M | $570000 |
| Deuda Neta | $2.5M | $4.2M | $26.0M | $5.1M | $5.7M | -$521000 |
| Capital Circulante | -$1.3M | -$3.9M | -$25.7M | -$12.5M | -$15.6M | -$2.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $149000 | $585000 | $233000 | $358000 |
| Activos Totales | $1.5M | $2.2M | $1.5M | $1.4M |
| Pasivos Totales | $5.4M | $5.1M | $5.6M | $4.9M |
| Patrimonio Neto | -$3.9M | -$3.0M | -$4.1M | -$3.5M |
| Deuda Total | $388000 | $570000 | $837000 | $701000 |
Flujo de Caja (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$2.8M | -$2.9M | -$30.5M | -$33.8M | -$10.1M | -$2.8M |
| Amortizaciones | $13920 | $14466 | $25000 | $28000 | $57000 | $65000 |
| Compensación en Acciones | $606509 | $97871 | $1.9M | $1.5M | $628000 | $2.0M |
| Cambio en Capital Circulante | $310590 | $984134 | -$29000 | $611000 | $1.5M | $106000 |
| Flujo de Caja Operativo | -$2.1M | -$1.8M | -$4.7M | -$4.8M | -$7.0M | -$7.5M |
| Inversiones (CapEx) | 0 | -$29936 | -$58000 | -$44000 | -$51000 | -$13000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$88.5M | 0 | -$200000 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.1M | -$1.9M | -$4.8M | -$4.8M | -$7.0M | -$7.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.6M | -$1.7M | -$1.5M | -$1.9M |
| Inversiones (CapEx) | 0 | -$5000 | -$2000 | -$9000 |
| Flujo de Caja Libre | -$1.6M | -$1.7M | -$1.5M | -$1.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $1.5M | 0 | $463000 |
Crecimiento y Márgenes (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +32.5% | +5.6% | -11.4% | -37.0% | +111.4% |
| Crecimiento Beneficio Neto (anual) | | -4.2% | -935.4% | -10.9% | +70.0% | +72.3% |
| Crecimiento BPA (anual) | | -5.3% | -1155.0% | -90.0% | +92.5% | +83.3% |
| Cambio en Acciones (anual) | | +0.0% | -18.9% | -41.6% | +296.3% | +58.7% |
| Crecimiento FCF (anual) | | +11.8% | -154.0% | -1.6% | -45.5% | -6.9% |
| Margen Bruto | 25.8% | -10.4% | -31.2% | -12.6% | -43.7% | -37.0% |
| Margen Operativo | -355.8% | -248.3% | -669.1% | -671.2% | -1493.8% | -711.3% |
| Margen EBITDA | -354.1% | -250.1% | -2637.4% | -3302.9% | -1543.2% | -196.3% |
| Margen Neto | -342.4% | -269.4% | -2641.0% | -3308.5% | -1575.3% | -206.1% |
| Margen FCF | -257.9% | -171.7% | -412.9% | -473.6% | -1093.9% | -553.1% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.1% | -0.1% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.14 | $-0.13 | $-0.39 | $-0.68 | $-0.25 | $-0.17 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $15.0M | $15.0M | $12.1M | $7.1M | $28.1M | $44.5M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | 234.63% |
| Rentabilidad sobre capital invertido | 362.69% |
| Rentabilidad sobre activos | -623.61% |
| Margen bruto | -68.82% |
| Margen operativo | -695.74% |
| Margen neto | -584.20% |
Salud financiera
| Deuda / Patrimonio | -0.20 |
| Ratio corriente | 0.28 |
Ratios Clave (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -52.11 | -50.50 | -4.16 | -0.17 | -3.78 | -18.33 |
| P/VC | -51.79 | -26.50 | -4.81 | -0.45 | -2.39 | -16.53 |
| P/V | 179.73 | 138.40 | 109.85 | 5.62 | 59.38 | 36.06 |
| Margen Bruto | 25.8% | -10.4% | -31.2% | -12.6% | -43.7% | -37.0% |
| Margen Operativo | -355.8% | -248.3% | -669.1% | -671.2% | -1493.8% | -711.3% |
| Margen Neto | -342.4% | -269.4% | -2641.0% | -3308.5% | -1575.3% | -206.1% |